Global Pharmaceuticals & Biotech Most Popular Stocks

Curaleaf Holdings

Market Cap: CA$2.7b

Produces and distributes cannabis products in the United States and internationally.

Liquidia

Market Cap: US$1.9b

A biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States.

Oxford Nanopore Technologies

Market Cap: UK£1.4b

Engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows the real-time analysis of DNA or RNA.

Voronoi

Market Cap: ₩2.7t

Researches, develops, and discovers small molecule kinase inhibitors in South Korea.

Jiang Zhong PharmaceuticalLtd

Market Cap: CN¥13.7b

Engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China.

Zhejiang Medicine

Market Cap: CN¥13.7b

Manufactures and sells life nutrition and pharmaceutical products in China.

Intellia Therapeutics

Market Cap: US$1.9b

A clinical-stage gene editing company, focuses on the development of curative genome editing treatments.

ANI Pharmaceuticals

Market Cap: US$1.9b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.

BGM Group

Market Cap: US$1.9b

Through its subsidiaries, operates as a pharmaceutical and chemical company in China.

Porton Pharma Solutions

Market Cap: CN¥13.3b

Provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial.

Jubilant Pharmova

Market Cap: ₹165.4b

Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.

Vitrolife

Market Cap: SEK 17.5b

Provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Cogent Biosciences

Market Cap: US$1.9b

A biotechnology company, focuses on developing precision therapies for genetically defined diseases.

Concord Biotech

Market Cap: ₹163.8b

A biopharma company, engages in the research and development, manufacture, market, and sale of pharmaceutical products in India and internationally.

Tsumura

Market Cap: JP¥276.6b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

Jiangsu Sinopep-Allsino Biopharmaceutical

Market Cap: CN¥13.0b

A biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.

Dyne Therapeutics

Market Cap: US$1.8b

A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.

Pharvaris

Market Cap: US$1.8b

A late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs covering angioedema and other bradykinin-mediated diseases.

Pharma Mar

Market Cap: €1.5b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Shenzhen Chipscreen Biosciences

Market Cap: CN¥12.5b

Shenzhen Chipscreen Biosciences Co., Ltd.

Henan Lingrui Pharmaceutical

Market Cap: CN¥12.5b

Produces and sells medicines in China.

Caplin Point Laboratories

Market Cap: ₹154.9b

Engages in the development, production, marketing, and export of generic formulations and branded products in India.

Consun Pharmaceutical Group

Market Cap: HK$13.5b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

GRAIL

Market Cap: US$1.7b

A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.

Sihuan Pharmaceutical Holdings Group

Market Cap: HK$13.5b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical and medical aesthetic products in the People’s Republic of China.

China Resources Boya Bio-pharmaceutical GroupLtd

Market Cap: CN¥12.4b

Engages in the blood product businesses in China.

Sarepta Therapeutics

Market Cap: US$1.7b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Guobang Pharma

Market Cap: CN¥12.3b

Engages in the research, development, production, and sale of products in the pharmaceutical and veterinary industries.

Vera Therapeutics

Market Cap: US$1.7b

A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.

Green Thumb Industries

Market Cap: CA$2.4b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Zhejiang Jolly PharmaceuticalLTD

Market Cap: CN¥12.3b

Engages in the research, production, and marketing of Chinese medicinal products in the People’s Republic of China and internationally.

Immunocore Holdings

Market Cap: US$1.7b

A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.

Chongqing Taiji Industry(Group)Ltd

Market Cap: CN¥12.2b

Develops, produces, and sells traditional Chinese and modern medicine products in China and internationally.

Yantai Dongcheng Pharmaceutical GroupLtd

Market Cap: CN¥12.2b

Engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas.

Harrow

Market Cap: US$1.7b

An eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products.

ChemoMetec

Market Cap: DKK 10.8b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.